Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
105 hedge funds and large institutions have $192M invested in Avid Bioservices, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 7 closing their positions.
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more capital invested
Capital invested by funds: $144M → $192M (+$47.3M)
28% more call options, than puts
Call options by funds: $903K | Put options by funds: $704K
16% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 31
7% more funds holding
Funds holding: 98 → 105 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$7.51M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.13M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$2.43M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
+$1.27M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$11.7M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$797K |
| 3 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$574K |
| 4 |
Renaissance Technologies
New York
|
-$516K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$454K |
CDMO Hedge Fund Activity: Q2 2020 in Review
105 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2020, worth a combined $192M — up 33% from $144M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CDMO positions and 7 closed out — a net gain of 7 holders — while 36 added to existing stakes and 31 trimmed.
The largest buyer was Millennium Management, adding an estimated $7.51M. The largest seller was ISZO Capital Management, cutting an estimated $11.7M.
- 105 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2020, up from 98 in Q1 2020.
- Funds reported $192M of Avid Bioservices, Inc. Common Stock stock for Q2 2020, up 33% quarter-over-quarter.
- 14 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2020 and 7 closed out, a net change of +7 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2020 was Millennium Management, an estimated $7.51M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2020 was ISZO Capital Management, an estimated $11.7M sold.
Based on aggregated 13F filings for Q2 2020.